J C Chou

Summary

Affiliation: Nathan Kline Institute
Country: USA

Publications

  1. ncbi Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder
    J C Chou
    Nathan Kline Institute, Orangeburg, NY 10962, USA
    Psychiatry Res 81:51-5. 1998
  2. ncbi Acute mania: haloperidol dose and augmentation with lithium or lorazepam
    J C Chou
    Nathan Kline Institute, Orangeburg, New York 10962, USA
    J Clin Psychopharmacol 19:500-5. 1999
  3. ncbi Pretreatment plasma HVA and haloperidol response in acute mania
    J C Chou
    Nathan Kline Institute, Orangeburg, NY 10962, USA
    J Affect Disord 59:55-9. 2000
  4. ncbi Haloperidol blood levels in acute mania with psychosis
    J C Chou
    Nathan Kline Institute, Orangeburg, New York 10962, USA
    J Clin Psychopharmacol 21:445-7. 2001

Collaborators

Detail Information

Publications4

  1. ncbi Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder
    J C Chou
    Nathan Kline Institute, Orangeburg, NY 10962, USA
    Psychiatry Res 81:51-5. 1998
    ..Further study of prolactin and clinical response to typical neuroleptics should focus on low neuroleptic doses...
  2. ncbi Acute mania: haloperidol dose and augmentation with lithium or lorazepam
    J C Chou
    Nathan Kline Institute, Orangeburg, New York 10962, USA
    J Clin Psychopharmacol 19:500-5. 1999
    ..Lorazepam 4 mg/day was insufficient to produce an advantage when added to low-dose haloperidol...
  3. ncbi Pretreatment plasma HVA and haloperidol response in acute mania
    J C Chou
    Nathan Kline Institute, Orangeburg, NY 10962, USA
    J Affect Disord 59:55-9. 2000
    ..Biological markers of clinical response to antipsychotics could be useful for optimizing drug treatment...
  4. ncbi Haloperidol blood levels in acute mania with psychosis
    J C Chou
    Nathan Kline Institute, Orangeburg, New York 10962, USA
    J Clin Psychopharmacol 21:445-7. 2001
    ..Haloperidol blood levels may be clinically useful in identifying patients who are nonresponsive because of low drug levels and, hence, in enhancing optimal haloperidol dosing for acute mania with psychosis...